Overview

Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Study of ABT-267 in both healthy volunteers and Hepatitis C virus (HCV) genotype 1 infected subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Treatments:
Antiviral Agents
Cytochrome P-450 Enzyme Inhibitors